Application Details

2013 LUNGevity Awards for Translational Research

LUNGevity has issued three Requests for Application (RFAs) for translational lung cancer research awards:

• Career Development Awards
• Early Detection Awards
• Targeted Therapeutics Awards

For all three of these awards:

• Letters of intent must be submitted by Monday, December 17, 2012. Those invited to proceed will be notified on January 18, 2013, and must submit a full application by Friday, March 1.
• Letters of intent and full applications must be submitted electronically via proposalCENTRAL.
• For complete information and instructions, click on the  provided link to the award’s RFA or visit https://proposalcentral.altum.com.

Career Development Awards:

LUNGevity’s Career Development Awards for Translational Research program was created to support a cohort of future research leaders who will keep the field of lung cancer research vibrant with new ideas. Applicants must be within the first five years of their faculty appointment. The Career Development Awards are mentored awards; a mentoring plan will be part of the required submission.

Projects that will be funded are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment.

Career Development Awards may be for a maximum of $100,000 per year for three years, for a maximum award of $300,000.

Note: LUNGevity will only consider one Career Development Award application per institution.

Click here to download the 2013 Career Development Award RFA.

Early Detection Awards:
2013 LUNGevity grant funds will be awarded to support research projects directed at new approaches to improve clinical methods for the detection of primary tumors. Projects are expected to have a direct impact on the early detection of lung cancer or a clear conceptual or experimental foundation for the future development of methods for early detection. The preference is for studies that are likely to result in patient benefit in the foreseeable future.

Applicants may apply as individuals or in teams of up to three investigators. It is strongly encouraged that teams be composed of principal investigators from different institutions.

Early Detection Awards may be for a maximum of $600,000: an annual maximum of $100,000 per year for two years for up to three principal investigators.

Click here to download the 2013 Early Detection Award RFA.

Targeted Therapeutics Awards:

2013 LUNGevity grant funds will be awarded to support research projects directed at the discovery and validation of biomarkers or novel targeted therapeutics that will make a difference in the clinical treatment and survival of patients.  

Applicants may apply as individuals or in teams of up to three investigators. It is strongly encouraged that teams be composed of principal investigators from different institutions.

Targeted Therapeutic Awards may be for a maximum of $600,000: an annual maximum of $100,000 per year for two years for up to three principal investigators.

Click here to download the 2013 Targeted Therapeutics Award RFA.